MiMedx sees FY26 revenue $340M-$360M, consensus $356.17M

The company said, “For 2026, MIMEDX (MDXG) currently estimates net sales to be in a range of $340 to $360 million and for adjusted EBITDA margin to be in the mid-to-high teens. Longer-term, the Company continues to expect to achieve annual net sales growth in the low double-digits as a percentage with an Adjusted EBITDA margin above 20%.”